Paul R. Vigano, identified as a ten percent owner of Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), reported sales of company common stock totaling approximately $43.68 million on June 3, 2026. The transactions involved the indirect disposition of shares at a price of $6.24 per share. The stock currently trades at $6.67, up slightly from the sale price, though shares have declined 7.5% over the past week.
According to a Form 4 filing, the sales were executed through various entities with which Mr. Vigano is associated. J.H. Whitney VII, L.P. disposed of 5,842,240 shares. Additionally, JHW Iliad Holdings LLC sold 1,047,913 shares, and JHW Iliad Holdings II LLC sold 109,847 shares. All shares were sold at a uniform price of $6.24.
Mr. Vigano is a Managing Member of J.H. Whitney Equity Partners VII, LLC, a Member of Project Iliad Managing Member, LLC, and a Senior Managing Director of J.H. Whitney Capital Partners, LLC. These roles connect him to the stockholder entities that held the shares. Mr. Vigano disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Following these transactions, J.H. Whitney VII, L.P. holds 13,450,547 shares, JHW Iliad Holdings LLC holds 2,412,602 shares, and JHW Iliad Holdings II LLC holds 252,899 shares. Other related entities, PSA Healthcare Investment Holdings LLC and PSA Iliad Holdings LLC, hold 15,523,810 shares and 1,426,034 shares respectively, though no transactions were reported for them on this date. Mr. Vigano’s direct ownership of Aveanna Healthcare common stock is 0 shares.
Despite the insider sale, InvestingPro analysis suggests the stock remains undervalued, with the company trading at a modest P/E ratio of 5.6. For investors seeking deeper insights into AVAH’s valuation and access to exclusive ProTips, the platform offers comprehensive analysis available at InvestingPro.Aveanna Healthcare HoldingsFollowAnalyze AVAHIncluded in our AI-picked strategies·Review strategies6.675▲+0.045(+0.68%)Real-time Data·11:55:47·USD1D1W1M6M1Y5YMaxCreated with Highcharts 11.4.818:0005/066.46.66.8Analyze AVAHIn other recent news, Aveanna Healthcare Holdings Inc. reported several significant developments. The company completed its acquisition of Family First Holding, LLC for $175.5 million in cash, expanding its reach with Family First Homecare’s 27 locations across seven states. This acquisition was funded with cash on hand and is expected to enhance Aveanna’s platform scale. RBC Capital upgraded Aveanna’s stock rating to Outperform from Sector Perform, citing solid execution on preferred payor relationships and the benefits of the Family First acquisition.
Additionally, Moody’s Ratings upgraded Aveanna Healthcare’s corporate family rating to B2 from B3, reflecting a reduction in leverage and improved business performance. This upgrade also included the company’s senior secured first lien bank credit facility and its speculative grade liquidity rating. The company also announced a repricing of its first lien credit facility and revolving credit facility, effectively reducing interest rate margins by 50 basis points. These recent developments highlight Aveanna’s strategic initiatives aimed at business volume growth and operational efficiency.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.Should you invest $2,000 in AVAH right now?ProPicks AI evaluates AVAH alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if AVAH is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?See More Stocks